Household income growth remained modest in the third quarter of 2024, according to new data from the Organization for Economic Cooperation and Development (OECD). Overall, real household income on a ...

Does GLP-1RA use impact the risk of thyroid cancer? GLP-1RAs are highly effective medications used to treat T2D and obesity while simultaneously conferring protection against cardiovascular ...

The OECD provides a comprehensive view of this matter in its analysis. A participant stands at the OECD headquarters in Paris on May 29, 2013. (Photo by ERIC PIERMONT/AFP ... [+] via Getty Images ...

Nearly half of patients with type 2 diabetes and two-thirds without discontinue GLP-1 receptor agonists within a year, with weight loss, income, and adverse events influencing discontinuation and ...

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists, or GLP-1.

A Google Trends study published in the National Library of Medicine found a significant and growing public interest in GLP-1 agonists between 2023 and 2024. Researchers estimate roughly half of U ...

This will allow the analytical laboratory to confirm the extent of GLP-1 receptor binding of the two FTS formulations in the tissue samples taken from the animals, providing an additional detailed ...

Share on Pinterest Scientists have found a link between certain eye conditions and GLP-1 medications. BONNINSTUDIO/Stocksy Past studies have found a potential link between semaglutide and the eye ...

However, the trial was halted prematurely and the data should be interpreted with caution. The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional ...

“Our study confirms the increased likelihood of being diagnosed with what appears to be low-risk thyroid cancer after treatment with GLP-1 RAs — but not because patients treated with GLP-1 RAs ...

Lexaria Bioscience (LEXX) provided progress updates on its Phase 1b, 12-week chronic study GLP-1-H24-4 underway in Australia. Lexaria has completed its submission to the human research ethics ...

Can GLP-1 Meds Harm Your Eyes? By Ernie Mundell HealthDay Reporter MONDAY, Feb. 10, 2025 (HealthDay News) -- Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss ...